Literature DB >> 29197881

What are the direct medical costs of managing Type 2 Diabetes Mellitus in Malaysia?

I M Feisul1, S Azmi2, A M Mohd Rizal3, H Zanariah4, N J Nik Mahir5, I Fatanah6, A N Aizuddin3, A Goh2.   

Abstract

INTRODUCTION: An economic analysis was performed to estimate the annual cost of diabetes mellitus to Malaysia.
METHODS: We combined published data and clinical pathways to estimate cost of follow-up and complications, then calculated the overall national cost. Costs consisted of diabetes follow-up and complications costs.
RESULTS: Patient follow-up was estimated at RM459 per year. Complications cost were RM42,362 per patient per year for nephropathy, RM4,817 for myocardial infarction, RM5,345 for stroke, RM3,880 for heart failure, RM5,519 for foot amputation, RM479 for retinopathy and RM4,812 for cataract extraction.
CONCLUSION: Overall, we estimated the total cost of diabetes as RM2.04 billion per year for year 2011 (both public and private sector). Of this, RM1.40 billion per year was incurred by the government. Despite some limitations, we believe our study provides insight to the actual cost of diabetes to the country. The high cost to the nation highlights the importance of primary and secondary prevention.

Entities:  

Mesh:

Year:  2017        PMID: 29197881

Source DB:  PubMed          Journal:  Med J Malaysia        ISSN: 0300-5283


  3 in total

1.  Comparing the cost, glycaemic control and medication adherence of utilizing patients' own medicines (POMs) versus usual dispensing among diabetic patients in an outpatient setting.

Authors:  Phei Ching Lim; Yin Ying Chung; Shien Joo Tan; Te Ying Wong; Durga Devi Permalu; Thean Kheng Cheah; Shueh Lin Lim; Chong Yew Lee
Journal:  Daru       Date:  2021-02-04       Impact factor: 3.117

2.  How Much Do We Know about the Biopsychosocial Predictors of Glycaemic Control? Age and Clinical Factors Predict Glycaemic Control, but Psychological Factors Do Not.

Authors:  Mohammad Farris Iman Leong Bin Abdullah; Hatta Sidi; Arun Ravindran; Paula Junggar Gosse; Emily Samantha Kaunismaa; Roslyn Laurie Mainland; Norlaila Mustafa; Nurul Hazwani Hatta; Puteri Arnawati; Amelia Yasmin Zulkifli; Luke Sy-Cherng Woon
Journal:  J Diabetes Res       Date:  2020-05-01       Impact factor: 4.011

3.  Process evaluation of enhancing primary health care for non-communicable disease management in Malaysia: Uncovering the fidelity & feasibility elements.

Authors:  Lee Lan Low; Fathullah Iqbal A B Rahim; Nur Aqlili Riana Hamzah; Mohd Safiee Ismail
Journal:  PLoS One       Date:  2021-01-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.